A Unique Geographical Analysis of Lung Cancer Patients in the State of Utah
R. Herde,W. Akerley,K. Kokeny,J. Ying,N. Hu,Y.J. Hitchcock
DOI: https://doi.org/10.1016/j.ijrobp.2012.07.1524
IF: 8.013
2012-01-01
International Journal of Radiation Oncology*Biology*Physics
Abstract:Purpose/Objective(s)Lung cancer is the No.1 cause of cancer death in men and women, and the overall survival of lung cancer patients is strongly associated with tumor staging. The state of Utah represents a unique geographic situation that may have an impact in cancer patients’ care. A significant portion of the population lives >50 miles from a major cancer center, especially considering that 20% of the state's 2.8 million people live outside of the Wasatch Front and Salt Lake City, where a major cancer center is located. In addition, the institution is the only National Comprehensive Cancer Network member institution in the intermountain west. Thus, HCH provides services to many patients outside of Utah living in the intermountain region. Due to this large area of service, logistical problems related to early diagnosis and the delivery of care arise. Clinical data show that any delay in initiating lung cancer staging and treatment adversely impacts disease progression and increases the risk of distant metastasis. We hypothesized that lung cancer patients living without proximity to a major cancer center may present with more advanced disease at diagnosis and their overall survival may be reduced.Materials/MethodsWe performed a retrospective analysis of clinical data acquired from the charts of 1,131 patients diagnosed with lung cancer from 1989 to 2009. We determined patient travel distance from the home address using Google Maps. Kaplan-Meier survival curves for different categories of distance were drawn and the log-rank test was used to test for differences in the survival functions. Cox regression was performed to test the effect of distance on survival times. Ordered logistic regression with proportional odds assumption was used to assess the effect of distance, which was treated as linear, on tumor grade.ResultsWe found that 22% of the patients lived within 50 miles and 44% lived within 100 miles. The overall absolute 1, 3 and 5-year survival rates of the entire study population were 40%, 14%, and 7% respectively. The mean overall survival and median survival were 18.2 and 8.4 months respectively. There was no impact on overall survival in subgroups of patients who lived ≤50, 50-100, 100-150, 150-200 or >200 miles from the institution (HR: 1.00, 95% CI (0.94, 1.07), p=0.91). Travel distance was not a significant factor affecting initial tumor stage at diagnosis (OR 1.10, 95% CI (0.96, 1.26), p=0.16).ConclusionsThe study showed patient travel distance to a major cancer center did not impact overall cancer staging or survival. These results may indicate that primary care in the rural intermountain west is comparable to a large metropolitan area for detection of lung cancers and timely referral to a tertiary cancer care center. Purpose/Objective(s)Lung cancer is the No.1 cause of cancer death in men and women, and the overall survival of lung cancer patients is strongly associated with tumor staging. The state of Utah represents a unique geographic situation that may have an impact in cancer patients’ care. A significant portion of the population lives >50 miles from a major cancer center, especially considering that 20% of the state's 2.8 million people live outside of the Wasatch Front and Salt Lake City, where a major cancer center is located. In addition, the institution is the only National Comprehensive Cancer Network member institution in the intermountain west. Thus, HCH provides services to many patients outside of Utah living in the intermountain region. Due to this large area of service, logistical problems related to early diagnosis and the delivery of care arise. Clinical data show that any delay in initiating lung cancer staging and treatment adversely impacts disease progression and increases the risk of distant metastasis. We hypothesized that lung cancer patients living without proximity to a major cancer center may present with more advanced disease at diagnosis and their overall survival may be reduced. Lung cancer is the No.1 cause of cancer death in men and women, and the overall survival of lung cancer patients is strongly associated with tumor staging. The state of Utah represents a unique geographic situation that may have an impact in cancer patients’ care. A significant portion of the population lives >50 miles from a major cancer center, especially considering that 20% of the state's 2.8 million people live outside of the Wasatch Front and Salt Lake City, where a major cancer center is located. In addition, the institution is the only National Comprehensive Cancer Network member institution in the intermountain west. Thus, HCH provides services to many patients outside of Utah living in the intermountain region. Due to this large area of service, logistical problems related to early diagnosis and the delivery of care arise. Clinical data show that any delay in initiating lung cancer staging and treatment adversely impacts disease progression and increases the risk of distant metastasis. We hypothesized that lung cancer patients living without proximity to a major cancer center may present with more advanced disease at diagnosis and their overall survival may be reduced. Materials/MethodsWe performed a retrospective analysis of clinical data acquired from the charts of 1,131 patients diagnosed with lung cancer from 1989 to 2009. We determined patient travel distance from the home address using Google Maps. Kaplan-Meier survival curves for different categories of distance were drawn and the log-rank test was used to test for differences in the survival functions. Cox regression was performed to test the effect of distance on survival times. Ordered logistic regression with proportional odds assumption was used to assess the effect of distance, which was treated as linear, on tumor grade. We performed a retrospective analysis of clinical data acquired from the charts of 1,131 patients diagnosed with lung cancer from 1989 to 2009. We determined patient travel distance from the home address using Google Maps. Kaplan-Meier survival curves for different categories of distance were drawn and the log-rank test was used to test for differences in the survival functions. Cox regression was performed to test the effect of distance on survival times. Ordered logistic regression with proportional odds assumption was used to assess the effect of distance, which was treated as linear, on tumor grade. ResultsWe found that 22% of the patients lived within 50 miles and 44% lived within 100 miles. The overall absolute 1, 3 and 5-year survival rates of the entire study population were 40%, 14%, and 7% respectively. The mean overall survival and median survival were 18.2 and 8.4 months respectively. There was no impact on overall survival in subgroups of patients who lived ≤50, 50-100, 100-150, 150-200 or >200 miles from the institution (HR: 1.00, 95% CI (0.94, 1.07), p=0.91). Travel distance was not a significant factor affecting initial tumor stage at diagnosis (OR 1.10, 95% CI (0.96, 1.26), p=0.16). We found that 22% of the patients lived within 50 miles and 44% lived within 100 miles. The overall absolute 1, 3 and 5-year survival rates of the entire study population were 40%, 14%, and 7% respectively. The mean overall survival and median survival were 18.2 and 8.4 months respectively. There was no impact on overall survival in subgroups of patients who lived ≤50, 50-100, 100-150, 150-200 or >200 miles from the institution (HR: 1.00, 95% CI (0.94, 1.07), p=0.91). Travel distance was not a significant factor affecting initial tumor stage at diagnosis (OR 1.10, 95% CI (0.96, 1.26), p=0.16). ConclusionsThe study showed patient travel distance to a major cancer center did not impact overall cancer staging or survival. These results may indicate that primary care in the rural intermountain west is comparable to a large metropolitan area for detection of lung cancers and timely referral to a tertiary cancer care center. The study showed patient travel distance to a major cancer center did not impact overall cancer staging or survival. These results may indicate that primary care in the rural intermountain west is comparable to a large metropolitan area for detection of lung cancers and timely referral to a tertiary cancer care center.